
Sign up to save your podcasts
Or


This week, the team shares a teaser of GOLD's latest catalyst interview with Mina Makar, Senior Vice President, Global Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca. He talks to Isabel about why he decided to leave pharmacy for pharma, his passion for tackling unmet needs and championing the patient perspective as well as his thoughts on how to be an effective leader.
If you're interested in learning more about the topic areas discussed in this episode, check out the following content:
Catalyst interview: Mina Makar on tackling unmet patient needs https://www.emg-gold.com/post/mina-makar-on-tackling-unmet-patient-needs
Turning patient insights into action https://www.emg-gold.com/post/turning-patient-insights-into-action
Our last catalyst: John Wahba on the medical affairs evolution https://www.emg-gold.com/post/john-wahba-on-the-medical-affairs-evolution
By EMJThis week, the team shares a teaser of GOLD's latest catalyst interview with Mina Makar, Senior Vice President, Global Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca. He talks to Isabel about why he decided to leave pharmacy for pharma, his passion for tackling unmet needs and championing the patient perspective as well as his thoughts on how to be an effective leader.
If you're interested in learning more about the topic areas discussed in this episode, check out the following content:
Catalyst interview: Mina Makar on tackling unmet patient needs https://www.emg-gold.com/post/mina-makar-on-tackling-unmet-patient-needs
Turning patient insights into action https://www.emg-gold.com/post/turning-patient-insights-into-action
Our last catalyst: John Wahba on the medical affairs evolution https://www.emg-gold.com/post/john-wahba-on-the-medical-affairs-evolution